Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lymphoma, Follicular × Drug Therapy × Clear all

Phase

Phase 2 3 Phase 3 2 Phase NA 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 SCLC 1 Retinoblastoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oligometastatic Disease 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced Resectable Rectal Cancer 1 Glioblastoma 1 Gestational Trophoblastic Disease 1 Gastrointestinal Neoplasms 1

Interventions

Rituximab 3 fludarabine phosphate 2 Etoposide 2 Cyclophosphamide 2 umbralisib 1 ublituximab 1 remdesivir 1 fludarabine 1 epratuzumab 1 aldesleukin 1 Whole-Body Irradiation 1 UE2343 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Standard of Care 1 Radiotherapy 1 Radioimmunodetection 1 Methotrexate 1 Melphalan 1 Hydrochlorothiazide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Drug Therapy 1 Dosage Forms 1 Carmustine 1 Carboplatin 1 COVID-19 Serotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00096460 2023-01-05

BMT CTN 0202

Medical College of Wisconsin

Phase 2/3 Terminated

30 enrolled 5 charts

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡